Vertigo, a common clinical syndrome characterized by the illusion of movement, poses a significant diagnostic challenge in medical practice. Despite its prevalence, the condition is often misunderstood and misdiagnosed, necessitating a comprehensive clinical approach for effective management.
Vertigo is not a disease, but rather a symptom of various underlying pathologies. It is typically a manifestation of vestibular dysfunction, which can arise from a multitude of factors, including benign paroxysmal positional vertigo (BPPV), Meniere's disease, vestibular neuritis, or labyrinthitis. It is crucial to distinguish vertigo from other forms of dizziness for precise diagnosis and treatment.
A thorough history and physical examination, including a detailed neuro-otological examination, form the cornerstone of vertigo evaluation. Identifying the pattern of vertigo episodes, associated symptoms, and triggering factors can provide valuable clues about the underlying etiology. The Dix-Hallpike and head impulse tests are essential bedside maneuvers to identify BPPV and vestibular neuritis, respectively.
While the clinical evaluation is fundamental, adjunctive diagnostic tools can augment the diagnostic accuracy. Audiometry and vestibular evoked myogenic potentials (VEMP) can help detect Meniere's disease, while imaging modalities like MRI may be required to rule out central causes of vertigo such as stroke or tumor.
The management of vertigo is primarily guided by its underlying cause. BPPV can be effectively treated with canalith repositioning maneuvers, while Meniere's disease requires a combination of dietary modification and medication. Vestibular rehabilitation therapy is a beneficial non-pharmacological approach for chronic vertigo.
Vertigo is a complex clinical entity that requires a comprehensive, systematic approach for effective diagnosis and management. By understanding its pathophysiology, refining our clinical skills, and utilizing appropriate diagnostic tools, we can significantly enhance the care we provide to patients suffering from this debilitating symptom.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation